Some medications, such as Ozempic (semaglutide), only have Food and Drug Administration (FDA) approval for the management of type 2 diabetes
The practical takeaway for patients is not to look for gray-market retatrutide online
& Christopoulos, A
In sum, current evidence positions GLP-1 RAs as a potential cardioprotective strategy in HF, with HF with preserved ejection fraction emerging as the clinically most relevant phenotype for the drug class, especially when occurring in people with obesity with and without diabetes
Nathanson D, Ullman B, Lfstrm U, Hedman A, Frick M, Sjholm A, Nystrm T: Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety